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Although the association of alkaline phosphatase
(APase) with murine fetal thymus up to 16 days gestation
and murine thymic lymphoma has been established, very
little work has been done to determine if the murine
lymphoma APase is similar to the fetal thymus APase. In an
effort to determine the nature of the relationship a bio¬
chemical characterization was performed. The placenta and
spleen were also included since previous biochemical exper¬
iments had shown lymphoma APase similar to these APases.
The parameters included pH optimum, heat inactivation, sub¬
strate ratios, Michaelis constant, activation and
inhibition. In addition, the electrophoretic mobility was
iii
determined in the presence and absence of neuraminidase
using the substrates alpha-naphthyl phosphate (NP) and
p-nitrophenyl phosphate (pNPP). The results indicate that
the lymphoma APase is very similar to fetal thymus,
placenta, and spleen APases. All APase activities had a pH
optimum of 10. Approximately 55% of the activity was in¬
activated at 55 C in four minutes. The APase activities
were all inhibited by ethylenediamine tetra-acetic acid,
L-homoarginine, and L-phenylalanine at the level of 100,
80 and 1.11% respectively. Magnesium activated each APase
activity by approximately 467o. Furthermore, the nucleo¬
philic buffers diethanolamine, 2-amino-2-methy1-1,3-pro-
pandiol, and tris(hydroxymethyl)aminomethane activated the
APase activities. The electrophoretic mobility of all
APases was similar and neuraminidase slowed the migration
of these APase activities. The 5-ocalization of each APase
was identical with the substrates NP and pNPP. These
results lend support to the hypothesis that the APase
activity which appears in thymic lymphoma might represent a
derepressed embryonic function. Thus, the murine thymic
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The association of alkaline phosphatase (APase) with
murine fetal thymus up to 16 days gestation and with murine
lymphoma has been established. Murine lymphoma APase
activity has been previously compared with that of several
normal tissues in addition to the APase activity in the
whole fetus and placenta at 16 days gestation. Because the
lymphoma APase was fovind to be similar to that of the
spleen and placenta APases, it was suggested that the APase
of lymphoma may represent a derepressed embryonic function.
However, to establish this, it is also necessary to compare
the lymphoma APase activity with the APase activity of the
fetal thymus.
The sensitive fluorometric assay for APase has made
such a comparison possible. The fluorometer has the advan¬
tages of being extremely sensitive and specific when
compared with a spectrophotometer. Fluorescence is a
direct measure of the absorbed light whereas the spectro¬
photometer measures the absorbed light indirectly as the
difference between the reference or 1007o beam and the
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transmitted beam. When the spectrophotometer is used to
measure low concentrations, the inaccuracies of measure¬
ment approach this difference and cannot be measured.
The goal of this research was to support or refute
the hypothesis that the APase activity which appears in
thymic lymphoma might represent a derepressed embryonic
function by biochemical comparisons. The substrate alpha-
naphthyl phosphate (NP) was chosen not only because it
gives a fluorogenic product but because it is the primary
substrate used to correlate the histochemical association
of APase in the murine fetal thymus and murine lymphoma.
The biochemical parameters investigated in this work
were pH optimum, heat inactivation, substrate ratio,
Michaelis constant (Kjjj), activation and inhibition. In
addition, electrophoresis was performed in the presence
and absence of neuraminidase with the substrates NP and
p-nitrophenyl phosphate (pNPP). The tissues used in this
comparison were the fetal thymus, the placenta, the spleen
and lymphomatous tissues. The placenta and spleen were
used since previous experiments had shown the APase
activity in these tissues to be similar to the APase




In vitro experiments show that alkaline phosphatase
(orthophosphoric monoester phosphohydrolase, E.C. 3.1.3.1)
catalyzes two basic types of reactions. The first type
involves the hydrolysis of monoesters of orthophosphoric
acid, thiophosphoric acid, pyrophosphate, fluorophosphate
and creatine-N-phosphate. There are systems in which
APase hydrolyzes monoesters of orthophosphoric acid at a
level two times greater than the monoesters of thiophos¬
phoric acid (Neumann et al., 1971, 1974; Fernley, 1971).
In contrast, there are reports of APases which have the
unique capacity to differentiate between oxygen and sulfur
links between the alcohol moiety and the phosphoryl group.
This indicates that the phosphorothioate esters are not
hydrolyzed in mammalian systems (Eckstein, 1966; Neumann,
1968; Ferhley, 1971). In the second type of reaction
APase acts as a phosphotransferase in which the phosphoryl
group is transferred to an acceptor molecule without the




APase is found in a large number of species. Non¬
mammalian sources include yeasts (Parish and Pelli, 1974),
bacteria (Heppel, 1971), echinoderms (Hsiao and Fjuii,
1963), insect larvae (Beckman and Johnson, 1964), annelids
(Bhoomittra, 1964), teleosts and elasmobranches (Bodansky
et al., 1931), amphibians (Licht, 1964), reptiles
(Richards et al., 1965) and birds (Motzok and Branion,
1959). Most mammalian species have been shown to possess
APase in tissues, blood, or secretions. The main mamma¬
lian tissues with high APase levels are those concerned
with active transport mechanisms such as the intestine and
kidney.
The ultrastruetural localization of APase in E. coli
is in the periplasmic space between the outer and inner
cell membrane (Heppel, 1971). In Dictyostelium discoideum
APase is in part associated with the cell surface (Parish
and Pelli, 1974). The intestinal APase is on the micro-
villar membranes of the absorbing epithelial cells of the
intestinal mucosa. The reaction is also prominent in the
Golgi zone, the smooth reticulum cisternae, and in the
dense bodies (Hugon and Borgers, 1966). Likewise, the
liver APase appears on the microvilli of the bile
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canaliculi, but it does not extend into the intracellular
spaces beyond the terminal bar (Fishman and Lin, 1973).
Hulstaert et al. (1973) localized placental APase not only
along the plasma membrane lining the microvilli and in the
vesicles of the syncyhiDtrophoblast but also along the
basal surface of the syncytiotrophoblast. APase lies in
the microvilli of the proximal tubular cells and in the
whole cell surface membrane bordering intercellular spaces
in the kidney (Goldfisher et al., 1964: Molbert et al.,
1960; Schmidt and Dubach, 1972).
The subcellular localization of APase activity in
HeLa cells is somewhat controversial. There are reports
of nuclear localization (Cox et al., 1967; Spencer and
Macrae, 1972) and of plasma membrane localization (Bosman
et al., 1968). Recently, Singer et al. (1974) showed
ultrastructural evidence for APase activity localized on
the plasma membrane in HeLa cells.
In their ultrastructural studies on Regan and non-
Regan isoenzymes of APase in human ovarian cancer cells,
Sasaki and Fishman (1973) correlated the ultrastructural
localization of APase with amino acid inhibition pattern.
In cases in which the Regan isoenzyme was present, the
ovarian cancer cells had enzymatic activity on the inner
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and outer membranes of the mitochondria which was
sensitive to L-phenylalanine (L-phe). In cases in which
the non-Regan isoenzyme was present, the cells had
enzymatic activity deppsited on the cell membrane. The
cell membrane enzyme was also sensitive to L-homoarginine
(H-arg) and resistant to L-phe. The significance of the
localization in these cells is as yet not clear.
While APase activity has been seen at intracellular
sites, it can be concluded that the majority of the
diverse cell types studied show APase activity in the
plasma membrane.
The biological role of APase in the cell is not yet
understood and its substrates m vivo are not yet defined.
Kay (1926) pointed out fifty years ago that the ability of
APase to act upon various substrates did not necessarily
indicate the function of this enzyme but might be merely
the fortuitous result of a particular type of molecular
configuration of fairly frequent occurrence in the cell.
Posen et al. (1969) also noted that the function of APase
may be unrelated to the hydrolysis of phosphate esters at
high pH. In fact, it has been demonstrated that APases
have their optimum reaction in an alkaline medium only at
high substrate concentrations; at substrate concentrations
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approaching the physiological levels of phosphoric esters
in the cell, the pH optimum of the enzjmie activity is
close to the physiological pH values (Morton, 1957).
Hence, the so-called APases can display almost their maxi¬
mum enzyme activity under the conditions of pH and
concentrations of phosphate esters in the cell.
The localization of APase suggests a function in
transport, possibly of phosphate across the cell membrane.
The work of Engstrdm (1961) showed that inorganic phos¬
phate can be incorporated into calf-intestinal APase,
since radioactive phosphorylserine was isolated after in¬
cubation of the enzyme with radioactive inorganic
phosphate. This reaction was inhibited by ethylenediamine
tetra-acetic acid (EDTA), indicating that metal is also
involved in this process. In 1964 Engstrom further
demonstrated that bovine liver APase incorporated phos¬
phate. Moog and Glazier (1972) also found that phosphate
uptake by duodenal ring preparations is inhibited by
either beryllium or L-phe, two strong inhibitors of
intestinal APase. Other investigators have shown that
APase may also function in the transport of fatty acids.
For example, Rufo et al. (1973) and Linscheer et al. (1971)
found enrichment with APase of the intestinal mucosa and
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of the blood in rats ingesting fats. In human studies the
thoracic lymph was rich in intestinal APase following the
intake of fat (Madsen and Tuba, 1953; Keiding, 1964, 1966).
APase is also implicated in the hydrolysis of dietary
sphingomyelin to ceramide and water-soluble compounds
(Linscheer et al., 1971).
Several studies have shown that APase from different
sources are inseparable from inorganic pyrophosphatase
(PPase) activity (Anderson and Nordlie, 1967; Moss et al.,
1967; Butterworth, 1968; Woltgens et al., 1971; Vreven et
al., 1973). The ability to hydrolyze PPase is also
demonstrated in highly purified human APase preparations
(Moss et al., 1967; Cox et al., 1967; Harkness, 1968).
Since pyrophosphate (PP) is a by-product of several bio¬
synthetic reactions including deoxyribonucleie (DNA) and
ribonucleic (RNA) synthesis, it has been suggested that PP
might be the natural substrate of APase acting as a PPase.
This could provide a mechanism by which the polymerization
of nucleic acids would be irreversible (Cox et al., 1967;
Slor and Bustan, 1973).
Fishman and Lin (1973) used Streptococcus faecalis as
a model system (Thompson, 1971) to explain how APase might
act together with other membrane phosphohydrolases and
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transferases to regulate the dimensions of the cell
membrane. In this system,growth was essentially the result
of interdigitation of cell wall synthetase and hydrolase
activities with an equilibrium in favor of synthetase. Im¬
balance in either of these two activities would lead to an
increase or a decrease in the size of the cell membrane.
By analogy, Fishman and Lin (1973) reasoned that the plasma
membrane in mammalian cells has enzymes which function in a
similar manner. This model provides a role for membrane
enzymes such as APase in some of the basic physiologic
functions of the membrane. For instance, the cleavage of
membrane phosphate esters could open up the membrane, pro¬
viding sites for polymer chain elongation catalyzed by the
specific synthetase and resulting in the biosynthesis of
the membrane. The hydrolase activity causing the opening
of the membrane could also allow for the entry and exit of
large molecules in and out of the cell.
Studies on the control of APase synthesis in vitro
lend themselves to the postulation of a potential function
of APase. Nitowsky et al. (1963) demonstrated that cells
grown in media with increased osmolarity exhibited
increased APase activity which is due to ^ novo synthesis.
Griffin and Cox (1966) studied the mechanism of
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prednisolone induction of APase in HeLa cell cultures.
Their studies revealed that an elevation in APase activity
by prednisolone required both RNA and protein synthesis.
Melnykovych et al. (1967), using synchronized cultures,
showed an increase in APase activity following completion
of mitosis and then a decrease in APase activity during DNA
S3nithesis. In addition, cyclic adenosine monophosphate
(cAMP), dibutyryl adenosine monophosphate and 5-bromodeoxy-
uridine have been shown to induce APase activity requiring
synthesis of both RNA and protein (Koyama and Ono, 1971,
1972; Koyama et al., 1972). Immunological methods showed
that the amount of enzyme protein was not increased (Ghosh
et al. , 1972). Therefore, Cox et al. (1971) and Ghosh et
al. (1972) postulated that a modifier substance was induced
which interacted with APase, resulting in increased
catalytic activity. Later, Melnykovych and Bishop (1973)
found that prednisolone induction of a heat stable APase in
HeLa cells was associated with an increase in glycogen, a
phenomenon which could be mimicked by administration of
cAMP. Further, cAMP has been shown to be involved in con¬
tact inhibition, in suppression of tumor growth, and in the
control of the immune response (Otten et al., 1971;
Ishizuha et al., 1971). There is, therefore, some indirect
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evidence suggesting that APase may be involved with cAMP
in the control of cell division.
Several possible functions of APase exists. It could
act to transport molecules such as phosphate and oleic
acid; as a PPase in nucleic acid sjmthesis; to regulate
the dimensions of the cell membrane; or, in related func¬
tions with cAMP, in the control of cell division. It is
known that APases from different organs are different.
Thus, the function of APase is most likely organ specific.
In addition, it is known that there is more than one APase
in certain organs. This means that the function of
different APases in a particular organ could reflect its
histochemical localization in that organ or even its histo-
chemical localization in the cells of that organ.
Heterogeneity of Alkaline Phosphatase
The evidence for the existence of species, organ and
even tumor specific variants of APase appears to be well
established. These isoenzymes differ in electrophoretic
mobilities, heat stability, sensitivity to inhibition by
amino acids and other chemical agents, pH optimum. Km
values, and immunologic reactivity.
The APase of coli is a dimer containing two
identical subunits, each with a molecular weight of 40,000
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to 45,000 daltons (Rothman and Byrne, 1963). The enzyme
contains four zinc atoms per molecule (Anderson et al,,
1975), two of which are firmly bound and probably have
structure preserving properties, whereas the others are
important for the catalytic process (Simpson and Vallee,
1968; Reynolds and Schlesinger, 1969; Lazdunski and
Lazdunski, 1969). Zinc may be replaced by cobalt, copper,
cadmium, nickel, or manganese (Lazdunski et al., 1969;
Csopak and Falk, 1970; Ahlers, 1974), but only the cobalt
enzyme shows catalytic activity (Ahlers, 1974, LeVine et
al. , 1975). The enzyme molecule also contains 1.3 0.3
gram atoms of magnesium (Anderson et al., 1975). Since
the heat inactivation is decreased when magnesium ions are
present in the assay, magnesium ions might have a
structure-stabilizing effect (Ahlers, 1974). Anderson et
al. (1975) demonstrated that magnesium serves to regulate
the mode of binding of zinc and increases the APase
activity.
There are three loci (pho A, pho R and pho S) in¬
volved in the sjmthesis of APase in jE. coli (Bracha and
Yagil, 1973). The locus pho A is the structural gene;
while the loci pho R and pho S (pho S pho T) are the two
regulatory genes (Bracha and Yagil, 1973; Kida, 1974).
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Human placenta was shown by Ries (1937) to exhibit
APase activity. This was confirmed later by Anagn and
Matsudaira according to Aleem (1971) and by Ahmed and King
(1960). Human placental APase as well as zebra, llam^,
alpaca, guanaco, and cow placenta APases are heat stable;
whereas the mouse, rat, monkey, baboon, reindeer, hamster,
rabbit, and dog placental APases are heat labile. In
addition, the goat, saigo, and pig placental APases form a
group with intermediate heat stability (Leroux and Perry,
1971).
Human placental APase differs from other human APases
in a number of respects. The placental enzyme is more
resistant to denaturation by physical or chemical agents.
It has its own immunological characteristics (Fishman et
al., 1968; Sussman et al., 1968). While placental and in¬
testinal APases are inhibited by L-phe and are resistant to
H-arg, they are distinguished by the neuraminidase effect.
Intestinal APase is a nonglycoprotein; while placental
APase is a glycoprotein (Ghosh and Fishman, 1968).
A number of isoenz3miic forms of placental APase exist.
Three common phenotypes, fast (F), slow (S) and inter¬
mediate (I), have been recognized by the mobilities of the
single major enzyme zone characteristic of each (Thomas and
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Moss, 1972). Genetic studies suggest that the phenotypes
are due to the operation of three autosomal allelic genes
controlling the production of F, S, and I phosphatase
isoenzymes. F, S, and I appear in individuals homozygous
for the respective phosphatase genes and phenotypes FS, FI,
and SI (three further phenotypes) correspond to the
heterozygous genotypes (Robson and Harris, 1967).
Little differences exist between these phenotypes ex¬
cept for the electrophoretic mobility. In terms of
structure, they probably differ no more than a change in a
single amino acid residue (Thomas and Moss, 1972). Nitra¬
tion reduces considerably the degree to which placental
APase is inhibited by L-phe (Sokolovsky et al., 1969;
Thomas and Moss, 1972).
Harkness (1968) and Ghosh and Fishman (1968) were able
to prepare placental APase of high purity. It has been
found to be a zinc metalloenzyme. Zinc has a functional
role in catalysis. Magnesium or cobalt are also required
for activity. Like E. coli APase, placental APase is a
dimer with each monomeric subunit having a molecular weight
of 58,000 daltons (Gottlieb and Sussman, 1968). The
neuraminic acid-containing nature of placental APase has
been demonstrated by chemical means and the sialic acid
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residues were shown to occupy terminal positions away from
the active center of the enzyme. Removal of sialic acid
affects the electrophoretic mobility but not the activity
of the enzyme (Warnes, 1972). The high molecular variant
(200,000 m.w.) can be converted to a lower molecular weight
variant (70,000 m.w.) by storage for about four months
while the process is reversible by equilibrium dialysis
(Ghosh and Fishman, 1968).
Carcinoembryonic Antigens in Human Alkaline Phosphatase
Derepression of the genome of the cancer cell is a
mechanism that is frequently used to explain the similarity
of new enzymes which are appearing in an ever increasing
number of cases of human cancers to enzymes of the embry¬
onic sources. These enzymes have been referred to as
carcinoembryonic antigens. There are also reports that the
serum, as well as the cancerous tissue of human cancer
patients, contain from 4.4 to 15% APase activity which is
similar to the human placental APase activity (Fishman et
al., 1968, 1968; Stolbach et al., 1969; Nathanson and Fish¬
man, 1971; Cadeau et al., 1974). In order to further
differentiate carcinoembryonic antigens, Fishman (1973) has
suggested that the APases which resemble the placenta be
called carcinoplacental antigens.
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The classical careinoplacental enzyme is the Regan
isoenzyme which was first discovered in a male patient with
bronchocarcinoma (Fishman et al., 1968). It is a heat
stable, L-phe sensitive, neuraminidase cleavable APase with
the same electrophoretic mobility as the placenta (Fishman,
1973). In fact, the Regan isoenzyme is considered to be
the same as the placental APase isoenzyme. Thus, the name
carcinoplacental is appropriate.
Another well documented carcinoplacental APase is the
HeLa cell APase. This APase was originally obtained from a
black female patient with cervical carcinoma. The TCRC-1
and the TCRC-2 sublines of the HeLa cells are of particular
interest. The TCRC-1 produces the Regan isoenzyme and is
induced by prednisolone. However, the TCRC-2 cell line
produces an APase isoenzyme which differs from the Regan
isoenzyme in that it is inhibited by H-arg, is heat labile
and is not induced by prednisolone. Studies with these two
sublines are providing useful information concerning the
relationship between the presence of the Regan isoenzyme
and chromosomal variations. Cox and McLeod (1964) sug¬
gested that APase production by cultured human cells could
provide an enzyme marker which might be useful in studying
regulation by mammalian genes. The biggest difference in
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the two cell lines occurs in the group of small acrocentric
chromosomes. Investigators have found that an increase in
the number of small acrocentric chromosomes corresponds to
an increase in APase specific activity (DeCarli et al.,
1963; Santachiara-Benerecetti et al., 1967). On the basis
of isoenzyme profiles of APase in prednisolone-treated
human cell populations, Fishman and Singer (1975) predict
that the Regan APase has a chromosomal locus different
from that of the non-Regan APase.
Still other carcinoplacental APase enzymes include the
Regan variant (Warnock and Reisman), the Nagao isoenzyme
and the Cha Go cell line. The Regan variant was found in
an hepatocellular cancer by Warnock and Reisman (1969).
Observations by Warnock and Reisman (1969) revealed that the
Regan variant was a moderately heat stable enzyme, inhibited
by L-phe, had an electrophoretic mobility faster than the
human intestinal APase, and was immunologically distinct
from the fetal APase protein. Later Higashino et al.
(1972) purified the enzyme and showed that it had some
properties similar to the placenta, some similar to the
liver and some unique. The unique properties were that it
was inhibited by L-leucine and had a lower Kjjj than the
placental enzyme. Nakayama et al. (1970) isolated the
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Nagao isoenzyme from a patient with pleural carcinomatosis.
The Nagao isoenzyme has also been reported in the metastat¬
ic adenocarcinoma of the bile duct (Nakayama et al., 1971;
Jacoby and Bagshawe, 1971). This isoenzyme is interesting
because while it is identical to the placental isoenzyme
immunologically and biochemically, it is inhibited by L-
leucine and EDTA. The Cha Go cell line is an epithelial
cell line which synthesizes chorionic gonadotropin in
vitro. It was derived from the metastatic tissue of a
patient with lung carcinoma (luduena et al., 1974). It is
immunochemically, biochemically, and functionally very
similar to the APase synthesized by the original tumor
tissue and by the normal placenta.
There is abundant data suggesting that the APase in
certain human tumors resembles the human placental APase.
Therefore, it appears that the ability to induce placental
APase activity is present in all cells whether male or
female. Furthermore, this APase is possibly expressed by
the activation of a phase of embryonic development.
Association of Alkaline Phosphatase with Murine Leukemia
The association of APase with murine leukemia has
been demonstrated histochemically using a variety of sub¬
strates. APase was originally observed in the endothelium
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of the arteries and arterial capillaries of the normal thy¬
mus in C57B1 mice, using the substrates bieta-glycerophos-
phate (GP) and adenosine triphosphate (ATP) by Smith et al.
(1958). Beta-glycerophosphatase (GPase) was also seen as a
rim at the surfaces or just inside the cell membranes of
lymphocytes and reticular cells in both the cortex and me¬
dulla of the thymus; while adenosine triphosphatase
(ATPase) was seen in the mesenchymal reticular cells. The
endothelial cells of the central and pulp arteries of the
spleen had GPase activity and the arteries and arterial
capillaries housed the ATPase activity. Yet, Kouvalainen
(1971) saw either no GPase activity or only very slight ac¬
tivity in the thymus. Later, Smith (1961, 1962) found no
APase activity in the normal thymus using the substrate NP.
However, alpha-naphthyl phosphatase (NPase) activity could
be seen on the thymocytes in AKR mice, a strain having a
high rate of spontaneous thymic lymphoma and x-irradiated
induced lymphoma in C57B1 mice, a low leukemic strain.
Both the spontaneous lymphoma in the AKR strain and the in¬
duced lymphoma in C57B1 mice are known to have a viral eti¬
ology (Gross, 1958; Lieberman and Kaplan, 1959; Haran-Ghera,
1967; Doell and Mathieson, 1970; Vredevoe and Harp, 1976).
Lagerlof and Kaplan (1967) and George (1974) found a
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low level of NPase activity in the mitotically active
cells (lymphoblasts) of the 16-day fetal thymus. Thus,
NPase activity is present in the fetal thymus up to 16
days gestation and in the thymic lymphoma, but is absent
from normal thymocytes in C57B1 mice.
The NPase activity is on the membrane and in the
endothelial cells of vessels in lymphoma cells. Some
activity is found in the cells surrounding the germinal
follicles of the normal spleen (Lumb and Doell, 1970;
Floyd, 1973). In the placenta NPase activity is seen in
the syntrophoblast and cytotrophoblast (Floyd, 1973). In
the whole fetus NPase appears to be both cytoplasmic and
membrane bound in the liver and cartilage and mainly mem¬
brane bound in the intestine (Floyd, 1973). APase
activity is also found in the envelope of murine leukemia
viruses (De The, 1966).
In order to follow the chronological appearance of
APase in relation to the development of a thymic lymphoma,
several investigators used both histochemical and biochem¬
ical analysis. Using the Gomori histochemical method,
Siegler and Rich (1967) and Wilson et al. (1972) found
APase activity in the lymphomatous thymus only after it
was at least three times the weight of the normal thymus in
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ICR/Ha Swiss mice. Their results suggest that APase
elevation is a secondary event occuring after the onset of
disease and that it is not a fundamental metabolic altera¬
tion concerned with the onset of murine lymphoblastic
leukemia. However, using the more sensitive azo dye
histochemical method, Lagerlof and Kaplan (1967)
correlated the appearance of APase (NPase) with malignant
transformation, ruling out the possibility, therefore, that
APase is associated with cellular proliferation. Further¬
more, the biochemical studies of Haran-Ghsra et al. (1972)
and Wilson et al. (1971) demonstrated that the increase in
APase (p-nitrophaiyl phosphatase) (pNPPase) activity was
correlated with actual pathogenesis of murine lymphatic
leukemia. Wilson et al. (1971) even showed that APase was
not associated with the leukemia virus in the absence of
malignant transformation.
Biochemistry of Murine Alkaline Phosphatase
The APase activities of the placenta, fetal, adult
and lymphomatous tissues have been characterized using
several parameters. Lumb and Doell (1970) showed the liver
and duodenum to be different in pH optimum, heat inactiva¬
tion, ratio of activity toward pNPP and GP and electro¬
phoretic mobility, while the spleen and lymphoma APases
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were shown to be similar by these same characteristics.
Cory et al. (1971) found normal liver APase activity
different from leukemic liver APase activity by its mag¬
nesium activation, while acid phosphatase was constant in
both. They termed the leukemic APase activity as
independent" by comparison with normal liver APase which
was activated three-fold by magnesium. In comparing
leukemic tissue APases with APase in the normal organ
source (leukemic spieen versus normal spleen), Neumann et
al. (1971) discovered that leukemic APase in the C57B1/6,
SJL/J and AKR mice hydrolyzed the substrate pNPP 2-30
times faster than the substrate cysteamine-S-phosphate
(GASP), whereas the normal organ source of APase had a
rate of hydrolysis of pNPP/CASP of 1-3. Thus, normal and
leukemic tissue APases are able to hydrolyze both sub¬
strates pNPP and CASP, with both normal and leukemic
tissue APases having a greater affinity for pNPP. While
both normal and leukemic tissue APases have a greater
affinity for pNPP, leukemic tissue APases (omitting the
leukemic thymus comparison with the normal thymus) have a
two-fold greater affinity for pNPP over normal tissue
APases. By this criterion APase from the normal spleen is
different from APase in the leukemic s|>leen.
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While doing a comparative electrophoretic study of
normal and leukemic tissues, Floyd (1973) discovered a
PPase activity distinct from pNPPase, GPase and NPase
activities of placental, whole fetus, spleen and leukemic
extracts. She termed the activity of pNPPase, GPase and
NPase as non-specific APase activity and the PPase activity
as specific APase activity on the basis of electrophoretic
separation and neuraminidase sensitivity. She also dis¬
tinguished the whole fetus from the other tissues on the
basis of neuraminidase resistance. Tisdale et al. (1975),
in an effort to determine the substrate specificity of the
leukemic tissues, further distinguished the PPase activity
by its nuclear localization, resistance to L-phe and EDTA,
substrate ratio and pH optimum. In addition, ATPase and
fructose-1,6-diphosphatase (FDPase) were distinguished from
the nonspecific APase by heat inactivation rate. ATPase
also had a high level of magnesium activation; while FDPase
was resistant to the action of EDTA. While studying the
effects of nucleophilic buffers on APase activation,
Prioleau (1975) demonstrated that APase could transfer
phosphate to nucleophilic buffers. Thus, APase is a phos¬
photransferase, as well as a phosphohydrolase. It can be
concluded from these data that lymphoma APase activity is
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similar to normal spleen and placental APase activities and
that the nonspecific APase activity is distinct from
ATPase, FDPase and PPase activities found in the crude
extracts.
The biochemical data obtained, thus far, shows that
murine thymic lymphoma APase activity is similar to normal
spleen and placental APase activities. Therefore, the





Inbred C57Bl/Ka mice were originally obtained from
Dr. Henry S. Kaplan at Stanford University. They were
maintained by brother-sister mating. The spleens were ob¬
tained from normal adult C57B1 mice. The 16-day whole
fetuses, 16-day placentas, and 16-day fetal thymuses were
taken from 16-day pregnant mice.
The lymphomas were induced in the C57BI mice by
urethan or a virus (C57LV) which was isolated from a
lymphoma induced with 6-mercaptopurine (Doell and
Mathieson, 1971). Some of the lymphomas were pooled, since
previous experiments had shown no differences in the lym¬
phomas. Lymphomas used were L-361, L-475, PLl, PL2, PL3,
and PL4. L-361 and L-475 were C57LV-induced lymphomas.
PLl contained lymphomas L-410, L-414, and L-435, which were
spontaneous. PL2 contained lymphomas L-336, L-346, L-312,
L-416, which were C57LV-induced, and L-380 which was
urethan-induced. PL3 contained L-165, L-189, L-302, L-304,
and L-325, which were C57LV-induced. PL4 contained
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lymphomas L-488 and L-493, which were urethan-induced, and
L-486, L-487 and L-489, which were C57LV-induced.
Preparation of Extracts
Extracts were prepared by homogenizing the tissue in
a glass homogenizer in 0.01 M tris(hydroxymethyl)amino-
methane (tris) at pH 7. For electrophoresis experiments,
the homogenized extract was centrifuged at 75,000 x g in a
Beckman L3-50 ultracentrifuge for 30 minutes. The
precipitate was treated with 1% Noniodet P-40 (Shell Oil,
Inc.) (NP40), incubated at 37 C for 15 minutes, and centri¬
fuged at 75,000 X g for 30 minutes. The NP40 treatment was
repeated twice on the precipitates and the three resulting
supernatants were pooled. The pooled supernatants and the
remaining precipitate were then treated with 307o butanol
and centrifuged at 75,000 x g for 30 minutes. The result¬
ing aqueous layer was dialyzed to remove the butanol.
For electorphoresis experiments, the fetal thymus and
lymphoma extracts were treated with 1.0% NP40 and incubated
at 37 C for 15 minutes. One of the fetal thymus extracts
had to be further concentrated changing the detergent




borate, and diethanolamine (DEA) were used at varying con¬
centrations in order to find the best buffer to use for
maximtim sample activity.
Fluorimetric Assay for Alkaline Phosphatase
The Turner model 111 was used for fluorimetric assays.
The fluorimetric assay was employed when using the sub¬
strate NP (Moss, 1960). The excitation of NP was at 336 nm
and the emission of NP was at 464 nm. The buffer was pre¬
incubated at 37 C for five minutes in a 4 ml reaction
volume. The substrate (0.052 mM) and the extract were
added to the buffer and the formation of alpha-naphthol was
recorded by fluorescence for one to five minutes at con¬
stant temperature. For the experiments to test the level
of inhibition with ethylenediamine tetra-acetic acid
(EDTA), the extract was preincubated with the buffer but no
magnesium chloride and the reaction initiated by the
addition of NP.
Spectrophotometric Assay for Alkaline Phosphatase
The Hitachi model 102 digital spectrophotometer was
used for the spectrophotometric assay for APase. The
Nissei Sangyo n-14A printer was used to record the enzyme
activity. The reaction was run for four minutes at 37 C in
buffer at pH 10. When using the substrate pNPP, the enzyme
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and 0.1 ml of 33.8 mM substrate were added to the buffer
in a total reaction volume of 1 ml. When using the sub¬
strate GASP, the enzyme and GASP (0.36 mg) were added to
the buffer with 0.5 mg 5,5-dithiobis(2-nitrobenzoic acid)
in a total reaction volume of 1 ml (Neumann, 1968). The
p-nitrophenol and cysteamine complex were measured at
400 nm.
Optimum pH
To determine optimum pH, the extracts were incubated
with the appropriate substrate with the pH varying from 9
to 10.5.
Heat Inactivation
Heat inactivation rate was determined by heating tubes
prepared for assay, including 5 mM magnesium chloride, for
varying times at 55 G prior to assay. The heat inactiva¬
tion rate is described in the equation
A = AqO"^^
where A^ is the unheated activity, A is the activity re¬
maining after time t and K is the heat inactivation rate
constant. The rate was determined by Least Square's analy¬
sis of the data expressed as the natural log of activity
versus time at 55 G.
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Activation and Inhibition
Experiments were performed to determine the level of
activation or inhibition by 5 mM magnesium chloride (Mg),
0.1 mM EDTA, 10 mM H-arg, 10 mM L-phe, 0.5 M ammediol buf¬
fer and 1 M DEA buffer. Percent activation or inhibition
was determined by comparison with the appropriate control.
Magnesium Determination
Magnesium ions were chelated by 8-hydroxyquinoline-5-
sulfonic acid. The resulting chelate exhibited fluores¬
cence at 500 nm when excited by the light of 360 nm
(Schachter, 1961). The working reagent contained 0.1 M
tris and 0.0025 M 8-hydroxyquinoline-5-sulfonic acid with
varying concentrations of Mg for the standard curve in a
total reaction volume of 4 ml. For Mg determination in the
tissue extracts, 1 microliter was added to 4 ml reaction
volume and fluorescence was measured. Magnesium content
was determined by referring to the standard curve (Fig. 1).
Kinetics
The enzyme reaction was carried out as indicated
above, using 0.104, 0.052, 0.026, and 0.013 mM NP as sub¬
strate. A Lineweaver-Burke plot of the results was used
to determine the Michaelis constant (K^) .
Fig. 1 Magnesium standard curve showing the





Preparation of the Sample. The extracts had a final con¬
centration of 107o sucrose, 0.5% Triton X 100 (Fishman,
1974) and 0.0l77o bromphenol blue tracking dye. Enzyme
activity was at least 0.40 micromoles NP per minute per ml.
Samples were treated with equal volumes of 10 xmits neura¬
minidase (Cl. perfringens Type V) per 0.05 ml de-ionized
water for 30 minutes at 37 C. The migration of
neuraminidase-treated enzyme was compared with that of an
untreated control.
Gel Casting. The running gel contained 8% acrylamine,
0.227o N,N-methylene-bisacrylamide, 1.647o tris, 0.056%
r /N,N,N,N-tetramethylenediamine, 8.8% 1 M hydrochloric acid
(HCl) and 0.25% ammonium persulfate. The running gel was
pipetted into electrophoresis tubes, water-layered immedi¬
ately and allowed to polymerize for 15 minutes. After
polymerization, the water was removed and the concentrating
gel was added. The concentrating gel contained 2.5%
acrylamide, 0.6257. N,N-methylene-bisacrylamide, 2.19% tris,
11.7% 1 M HCl, 0.75% N,N,N,N-tetramethylethylenediamine,O.00057o riboflavin, and 10% sucrose. The concentrating
gel was layered with the upper buffer and allowed to poly¬
merize by exposure to ultra-violet light for 30 minutes.
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Buffers. The upper and lower buffers contained 0.10 M
tris-borate at pH 9.5. The upper buffer also contained
0.57o Triton X 100.
Electrophoretic Separation. Current was applied using a
Vokan power supply. For the first 5 minutes, constant cur¬
rent was applied at 1 mA per tube and then for the next 35
minutes at 4 mA per tube. The power was switched to
constant voltage at 200 V for 80 minutes.
Gel Removal. Gels were removed from the tubes by submerg¬
ing them in a pan of cold water and ringing them with a
cannula.
Staining Procedures
Azo-stain. The azo-dye method used was according to
Manheimer and Seligman (1948) as modified by McKay et al.
(1953) with the following modifications: 1 mg of Fast Blue
RR salt and 1 mg maphthol AS-MX phosphoric acid disodium
salt were ground in 1 ml of 0.2 M tris buffer (pH 10) with
5 rriM MgCl2« This mixture was poured on the gel and placed
in the refrigerator for 40 minutes. The stain was rinsed
off the gel and more stain was applied if necessary.




All data are reported as the mean and standard devi
ation of at least three experiments. A student's t-test
was performed to determine significance, using the





Table 1 shows that increasing the molarity of borate
buffer inhibits the APase activity. It was thought that
borate might be a neutral buffer which could be used as a
control for the experiments with nucleophilic buffers.
However, this was not the case, for borate definitely in¬
hibited the APase activities with the concentrations used.
To achieve the maximum efficiency on the fluorometer, a
number of nucleophilic buffers were tried to determine
their sensitivity level, as well as to compare their
ability to activate APase. The results show that increas¬
ing the molarity of the nucleophilic buffers increases the
APase activity (Table 2). In comparing the nucleophilic
buffers, tris, ammediol and DEA, it was found that DEA was
the best activator of APase (Table 3). In addition, DEA
would zero at 30 X sensitivity on the fluorometer, making
it 61.63-fold more sensitive than ammediol which is 1.90-
fold more sensitive than tris.
The NPase activities of all four tissues were
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Table 1. The effect of varying concentrations of
borate buffer on alkaline phosphatase
activity
Tissue 0.05 M Borate 0.50 M Borate
Lymphoma 68.0 t 9.2a 89.1 t 1.6
Spleen 51.8 t 6.1 86.9 t 1.7
Placenta 54.3 t 10.9 82.9 + 6.3
Fetal Thymus 65.1 t 5.3 82.6 + 3.9
The percent inhibition of alkaline phosphatase
activity by borate buffer compared to activity
in 0.05 M ammediol buffer expressed as the mean
and standard deviation of at least three
experiments.
Table 2. The effect of various concentrations of buffers on alkaline
phosphatase activity
Buffer 0.05 0.10 M 0.50 M 1.00 M
Tris(hydroxymethyl)aminomethane l.OOb 3.16 4.71 4.65
2-amino-2-me thy1-1,3-p ropandio1 1.00 1.71 2.71 np^
Die thanolamine 1.00 1.25 2.60 2.69
0^
Concentration of the buffer.
■L
The alkaline phosphatase activity in each buffer is compared with the
0.05 M buffer as the control. The numbers given represent the ratio
of APase activity in each buffer divided by the APase activity in
0.05 M of buffer indicated.
‘^np means that experiment was not performed because the particular
buffer would not zero at the sensitivity (3X) used.
Ui
o^
Table 3. Compafison of each buffer concentration with ability to activate
alkaline phosphatase activity
Buffer 0.05 0.10 M 0.50 M 1.00 M
Tris(hydroxymethyl)aminomethane l.OOb 1.00 1.00 1.00
2-amino-2-methyl-l,3-propandiol 1.90 1.03 1.10 np^
Die thanolamine 2.88 1.11 1.59 1.66
^Concentration of the buffer.
t>The figures given represent the ratio of APase activity in buffer at
particular molarity divided by tris(hydroxymethyl)aminomethane at same
molarity indicated.
•^np means that the experiment was not performed because the particular
buffer would not zero at the sensitivity (3X) used.
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activated by ammediol and DEA (Table 4).
Biochemical Characterization
Figure 2 shows the pH optima for the tissues tested.
As shown in the Fig., lymphoma, spleen, placenta, and fetal
thymus extracts all have an APase activity with a pH
optimum of 10 using the substrate NP.
Figure 3 shows the heat inactivation of all APase ac¬
tivities. It is clear that all tissues have a similar
pattern of inactivation. A statistical analysis of the
heat inactivation rates verifies this conclusion (Table 5).
Table 6 shows that magnesium activated all APase
activities in 0.05 M buffer. However, in some cases,
magnesium was inhibitory (up to 20%) in high molarity
buffers.
Table 7 shows that EDTA inhibited the APase activities
approximately 31% using the substrate NP. Previous experi¬
ments showed that EDTA inhibited the APase activities 96-10C%
using the substrate pNPP. In performing the spectrophoto-
metric assay, the enzyme with the buffer containing EDTA was
preincubated, the substrate was added, and the reaction was
run for 30 minutes. At the end of the reaction, the product
that formed was measured. When the fluorometer was used,
the buffer containing EDTA was preincubated and the enzyme
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Table 4. The level of activation of alkaline phosphatase
activity
Tissue Ammediol^ Diethanolamine^
Lymphoma 1.24 ± 0.29 2.88 + 0.32
Spleen 1.91 ± 0.14 2.81 t 0.11
Placenta 1.65 t 0.26 2.78 t 0.18
Fetal Thymus 1.63 t 0.64 2.87 t 0.43
^The activity of 0.5 M ammediol divided by the activity
of 0.05 M ammediol expressed as the mean and standard
deviation of at least three experiments.
^The activity of 1 M diethanolamine divided by the
activity of 0.05 M diethanolamine expressed as the
mean and standard deviation of at least three
experiments.
Fig. 2. The pH optimum of alkaline phosphatase
activities of placenta, spleen, lymphoma
and fetal thymus using the substrate
alpha-naphthyl phosphate.
alpha-naphthylphosphateI M O alpha-naphthylp osp atein
Fig. 3. Heat inactivation of alkaline phosphatase
activities of placenta, spleen, lymphoma,
and fetal thymus. The natural logarithm
of the activity remaining is plotted
against the time incubated at 55 C in

















^The rate of heat inactivation is determined by
plotting the slope of the natural logarithm of
the activity remaining versus the time heated
at 55 C.
^The mean and standard deviation were obtained from
at least three experiments.
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Lymphoma 1.46 t 0.21^ 0.91 ± 0.06^
Spleen 1.46 t 0.16 0.81 t 0.11
Placenta 1.46 ± 0.31 0.86 ± 0.06
Fetal Thymus 1.47 t 0.17 0.87 t 0.05
^Concentration of buffer.
^The activity of 0.05 M diethanolamine with 5 mM
magnesium divided by the activity of 0.05 M
diethanolamine without magnesixim expressed as the
mean and standard deviation of at least three
experiments.
^The activity of 1.0 M diethanolamine with 5 mM
magnesium divided by the activity of 1.0 M
diethanolamine without magnesium expressed as the
mean and standard deviation of at least three
experiments.
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Table 7. The level of alkaline phosphatase inhibition










aThe mean and standard deviation were obtained from
at least three experiments.
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and substrate were added at the same time. The reaction
was measured for one to five minutes. In order to deter¬
mine if the same enzyme hydrolyzed the substrates NP and
pNPP or if the difference in EDTA inhibition was a
reflection of the assay system, a time curve of the EDTA
inhibition was performed using the substrate NP. Figure 4
shows that the APase activity rapidly decreases with in¬
creased preincubation of the enzyme with EDTA. After 20
minutes preincubation, 97-1007o of the APase activity is
lost. Therefore, the difference in EDTA effect shown in
Table 7 is due to a difference in the assay system rather
than indicating that the substrates pNPP and NP are
hydrolyzed by different enzymes.
The level of APase inhibition by the amino acids L-phe
and H-arg is shown in Table 8. In low molarity nucleo¬
philic buffer, the APase activities are inhibited 100% by
H-arg and approximately 467o by L-phe; whereas in high
molarity buffer the APase activities are inhibited approxi¬
mately 817o by H-arg and 7.5% by L-phe.
Substrate ratios indicate that the pH 10 APase
activities of lymphoma and fetal thymus hydrolyze pNPP and
NP with approximately the same level of activity (Table 9).
Michaelis constants (Kj^) for the NPase activities of all
Fig. 4. A time curve of ethylenediamine tetra-acetic
acid (EDTA) inhibition showing the effect of
EDTA on alkaline phosphatase activity when
the preincubation times of the enzyme was


































^Concentrationofthebuff rdiethanolami e. ^Themeanandstandarddeviationw reobta n dfr mtl stthre experiments.
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Table 9. Substrate ratio of alkaline phosphatase
activity
Tissue Substrate Ratio^
Lymphoma 1.03 t 0.16^
Spleen 0.76 t 0.17
Placenta 0.91 + 0.01
Fetal Thymus 1.01 t 0.16
Substrate ratio is the ratio of activity using the
substrate alpha-naphthyl phosphate divided by the
activity using the substrate p-nitrophenyl phosphate.
^The mean and standard deviation were obtained from at
least three experiments.
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four tissues in Table 10 show that all APases have a
similar affinity for the substrate NP, Student's t-test
showed that the substrate ratio (Table 9) and the
(Table 10) values were not significantly different for the
different APases (>0.05).
Electrophoretic Analysis
In attempting to find the best conditions for APase
localization after electrophoresis, several experiments
were performed. Using different concentrations of tris,
ammediol, and DEA, it was decided that, if post-coupling
(incubating the gel in the substrate for the appropriate
time, then adding the coupling reagent) was performed, tris
was the buffer of choice. The low malarity buffers were
just as good as the high molarity buffers when looking at
alpha-naphthol fluorescence under ultra-violet light. High
molarity buffers coupled to the dye themselves. This pre¬
vented the dye from coupling with the alpha-naphthol.
Surprisingly, 1 M DEA was the worst buffer to use for
electrophoretic staining. Figure 5 shows the APase activi¬
ties in the placenta and whole fetus. In this particular
electrophoretic run many bands of APase activity were found
in the placenta and two bands of APase activity were found
in the whole fetus. Figure 6 shows the importance of small
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Table 10. The Michaelis constant for alkaline
phosphatase
Tissue Michaelis Constant (mM)
Lymphoma 0.024 t 0.007^
Spleen 0.034 ± 0.004
Placenta 0.030 t 0.016
Fetal Thymus 0.021 ± 0.007
Q
The mean and standard deviation were obtained from at
least three experiments.
Fig. 5. Electrophoresis of alkaline phosphatase
showing isoenzymes of NPase activity. P
represents the placental extract; W
represents the whole fetal extract;




Fig. 6. Electrophoresis of alkaline phosphatase
showing the effect of varying the volume
of placental extract. A-10 microliters
of placental extract. B-lOO microliters
of placenta extract; * represents the
tracking dye, bromphenol blue. Both





initial volumes (10>) versus larger volumes (100>) of the
placenta extract. While both volumes contain equivalent
APase activity, the smaller volume has sharper resolution.
Both bands of APase activity were in the larger volume, but
they were fainter and more diffuse. Figure 7 shows the
electrophoretic patterns of APases from all five tissues
using the substrate NP. The placenta, spleen, lymphoma and
fetal thymus APases have a similar electrophoretic
mobility. The lymphoma and fetal thymus APases have
identical electrophoretic mobilities. The whole fetus
APase definitely has a distinct electrophoretic mobility.
In comparing the effect of neuraminidase (Figure 8) the
lymphoma APase and faster migrating APase of the whole
fetus are slowed by neuraminidase. The neuraminidase
treatment significantly retards the tailing in the placenta
and spleen extracts. Such retardation may represent an
action on the APases in these extracts, although the total
migration of APase is not retarded by these extracts. The
fetal thymus APase is significantly slowed by the
neuraminidase treatment (Figure 9), as is the lymphoma
APase (Figure 8). All tissues have pNPPase activity
(Figure 10). Figure 11 compares the electrophoretic mobil¬
ity of the NPase and pNPPase activities of all tissues.
Fig. 7. Electrophoresis of alkaline phosphatase
showing NPase activity. P represents the
placental extract; S represents the spleen
extract; W represents the whole fetal
extract; L represents the lymphoma extract;
F represents the fetal thymus extract;
* represents the tracking dye, bromphenol blue.
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Fig. 8. Electrophoresis of alkaline phosphatase
showing NPase activity in the presence and
absence of neuraminidase. P represents
the placenta extract; S represents the
spleen extract; W represents the whole
fetus extract; L represents the lymphoma
extract; n indicates that extract was
treated with neuraminidase; * represents
the tracking dye, bromphenol blue.
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Fig. 9. Electrophoresis of alkaline phosphatase
showing NPase activity of the fetal thymus
in the presence and absence of neuraminidase.
F represents the fetal extract; n indicates
that extract was treated with neuraminidase;




Fig. 10. Electrophoresis of alkaline phosphatase
showing pNPPase activity. P represents
the placenta extract; S represents the
spleen extract; W represents the whole
fetus extract; L represents the lymphoma
extract; F represents the fetal thymus
extract; * represents the tracking dye,
bfomphenol blue.
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Fig. 11. Electrophoresis of alkaline phosphatase
comparing pNPPase and NPase activities.
P represents the placental extract; S
represents the spleen extract; W represents
the whole fetus extract; L represents the
lymphoma extract; F represents the fetal
thymus extract; a indicates pNPPase
activity; b indicates NPase activity;
* represents the tracking dye, bromphenol
blue.
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Each tissue APase activity appears to have NPase and
pNPPase activities with identical electrophoretic mobil¬
ities. The fetal thymus APase appears to have a different
mobility from the lymphoma APase in Figures 9, 10 and 11.
This difference in mobility could be due to a higher
detergent content in this fetal thymus extract.
CHAPTER V
DISCUSSION AND CONCLUSION
This biochemical comparison was performed to determine
if the APase of murine lymphoma represents a derepressed
embryonic function. No significant differences among the
lymphoma, spleen, placenta, and fetal thymus APases have
been shown by the pH optimum, heat inactivation, activation
by magnesium, inhibition by EDTA, L-phe and H-arg or sub¬
strate ratios. The mobility of the APase of the lymphoma
and fetal thymus extracts was significantly slowed by neura¬
minidase. The placenta and spleen APase activities were
slowed to the level of the top of the broad migrating band
of APase activity. All tissue APases have both NPase and
pNPPase activities with identical mobilities, indicating
that NPase and pNPPase are activities of the same enzyme.
Previous experiments showed that NPase and pNPPase
were non-specific APase activities of the same enzyme.
Furthermore, these experiments showed that neuraminidase
inhibited the mobility of the placenta, spleen and lymphoma
APases using the substrates NP and pNPP (Floyd, 1973).
The difference in the treatment of extracts could account
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for the differences seen in these APases. From Figures 5
and 6 it can be seen that the isoenzymes are varying in
the placental extracts. It appears that there are two
isoenzymes present in the placenta, & feature not noted
previous in the work of Floyd (1973). Better resolution
of the placenta APase isoenzyme is due to the use of the
detergent Triton X 100 in the electrophoretic separation.
In electrophoresing the same placental extract (freezing
and thawing several times), it appears that the number of
bands in the placenta varies, while the difference in
mobilities between the slower and faster APase decreases.
It appears that either the placental extract has a low
level of neuraminidase present which is cleaving some
carbohydrate away from the enzyme or that a difference in
buffer ionic strength coupled with using the same voltage
caused the observed differences in pattern (Figures 6 and
7) . The spleen and lymphoma also had two bands of APase
originally (Figure not shown) and the inhibition of
migration by neuraminidase was apparent. What appears ob¬
vious from these observations is that the carbohydrate
content in the lymphoma and fetal thymus APases may not be
the same as the carbohydrate content in the placenta and
spleen APases. This would not affect the stability or
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catalytic properties of the enzyme (Wames, 1972), but it
might change the antigenic properties of the enzyme
(Usategui-Gomez et al., 1969). Usategui-Gomez et al.
(1969) found that removal of the carbohydrate from APase
changed the ability of the enzyme to cause agglutination of
the H-1 virus. Numerous investigators report no effect on
catalytic activity of APase by removing the carbohydrate
from the enzyme. Another very obvious effect of neura¬
minidase treatment is that tailing is significantly
reduced. The differences in carbohydrate content, even in
the tissue extracts, could reflect the difference in
membrane location of the APases.
While it was known that the whole fetus was different
from the lymphoma APase, since it contains APases from
several tissues, its electrophoretic profile was re-examined
with the other tissue APases. This experiment clearly shows
that the faster moving band of the whole fetus is slowed by
neuraminidase. Floyd (1973) showed no effect on neura¬
minidase, but from looking carefully at the photographs, it
appears that the faster migrating band of APase in the whole
fetus was fainter than the control.
From these results, it can be concluded that the
lymphoma, fetal thymus, placenta and spleen APases are
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similar. It is not surprising that the fetal thymus,
adult spleen and placenta APases resemble the lymphoma
APase. The APase activity is seen in the cell membrane of
the fetal thymus up to 16 days gestation (Lager16f and
Kaplan, 1967). The APase of the adult spleen is in the
thymic-dependent areas of the spleen (Floyd, 1973). It is
known that lymphocytes must undergo dedifferentiation in
certain immunological functions. The placenta APase
activity is in the cell membrane of the fetal portion of
the placenta (Hulstaert et al., 1973). Thus, histochemical
localization of APase and association of APase with dedif¬
ferentiation help make it clear why these APases might be
similar.
Because all the murine APases tested are similar, the
lymphoma APase may represent a derepressed embryonic
function. The idea that one of the mechanisms of malignant
transformation is the derepression of embryonic functions
is not unique. The phenomenon of embryonic antigens and
isoenzymes appearing in human and experimental tumors is
well established. In fact, cancer and differentiation
have been closely linked through much of the history of
cancer. The data thus far suggest that a library of genes
exist which are concerned solely with the early
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embryogenesis and that some of these genes may be re¬
expressed in cancer (derepression of embryonic gene
functions). Indeed the mechanisms which allow the embryo
to escape immune destruction may also allow the tumor to
escape immune destruction. If this is the case, then, in
cancer one may be fighting his own genes.
Although the function of APase is not known with
certainty, it is possible to speculate on a possible func¬
tion from these experiments coupled with information
obtained from the literature. The APase of murine l5miphoma
has several known characteristics which may be important in
the consideration of a potential function. APase is acti¬
vated by sodium, potassium (Williams, 1971), magnesium
ions, high molarity nucleophilic buffers and is inhibited
by EDTA, L-phe and H-arg. APase has been shown to transfer
phosphate to high molarity nucleophilic buffers (Prioleau,
1975). One suggestion was that APase may be functioning as
a PPase which removes one of the products of DNA and RNA
polymerase activity and, therefore, shifts the equilibrium
in favor of S3mthesis. This possibility has been ruled out
by the work of Floyd (1973) and Tisdale et al. (1975) be¬
cause PPase activity was demonstrated to be clearly
distinct from APase activity. The APase activity
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associated with murine lymphoma hydrolyzes pNPP, NP and GP,
indicating a range of phosphate donors. It appears that
the specificity of the APase is probably with the acceptor
of the phosphate rather than the donor of phosphate. A very
interesting possibility is that APase acts as a protein
kinase in cAMP-related cell membrane events. The amino
acid inhibition patterns support this contention. L-phe
inhibits APase in low molarity nucleophilic buffer but to a
markedly less extent in high nucleophilic buffer, hinting
that it competes with the nucleophilic buffer which pos¬
sibly acts as a natural acceptor of phosphate in vivo. It
is possible that H-arg works at this site also, since its
level of inhibition is slightly reduced. So, the function
of APase may have something to do with its ability to act
as a transphosphorylase.
An interesting observation was that magnesium is in¬
hibitory at high nucleophilic buffer concentrations.
Magnesium probably works at the catalytic site rather than
aiding in the stability or regulating the access to the
active site of the enzyme.
These results are in general agreement with other re¬
ports of biochemical characterization of murine leukemic
APase. Lumb and Doell (1970) found the lymphoma APase
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activity to be similar to the low level of APase in the
normal spleen. Cory et al. (1971) have identified a new
APase activity in leukemic livers which was indepen¬
dent" when compared to the normal liver APase which was
activated three-fold by magnesivim. However, their "Mg*^-
independent" isoenzyme was activated 46%, the same level of
activation that was observed in these experiments. Like¬
wise, Neumann et al. (1971) stated in the summary that
magnesium was inhibitory but showed inhibition with 60 tiM
magnesium and variable (307o to 807o) activation by 1 mM
magnesium. Lumb and Doell (1970), Floyd (1973) and Tisdale
et al (1975) found the electrophoretic mobilities of the
lymphoma, spleen and placenta APases were similar using the
substrates NP. Floyd (1973) further states that the APises
were similar electrophoretically using the substrates pNPP,
GP and PP. However, she found the PPase activity clearly
distinct from the GPase, NPase and pNPPase activities which
were similar. The whole fetus was found to have a similar
electrophoretic mobility but was distinguished from the
other APases by its resistance to neuraminidase. Moore
(1975) and Tisdale et al. (1975) further distinguished
APase activity from the PPase, ATPase and FDPase activities
by certain biochemical criteria. Thus, they have an APase
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activity which hydrolyzes the substrates NP, pNPP and GP
but is clearly not associated with activity of PPase,
ATPase, or FDPase. Because these studies were performed on
crude extracts, purified APase enzyme may have a low level
of affinity for these substrates as a function of its
hydrolase activity. All reports show a similar heat in¬
activation pattern which is in agreement with these data,
that is, approximately half the activity is destroyed by
55 C in 5 minutes.
In an electrophoretic characterization of extracts
from normal, leukemic and fetal mouse tissues, Tyndall
et al. (1971) showed that esterase and lactose dehydrog¬
enase profile changes were similar in the leukemic and
fetal thymus and fetal spleen extracts. Microdensitometric
analyses showed a decrease of prealbumin and haptoglobin
esterase activity with concomitant increase of postalbumin
esterase in both fetal and leukemic thymuses and spleen
tissues. So while Tyndall et al. (1971) did not study the
APase profiles, they did find from their studies that the
leukemic tissues were similar to the fetal spleen and
thymus tissues.
A comparison of the murine lymphoma with certain human
tumors APases is shown in Table 11. The murine lymphoma
Table 11. Properties of human tumors and murine lymphoma alkaline phosphatases






Lymphoma 9% 82% labile 100% .03 +
cell
membrane











stable 34% 1.1 + 4
HeLa





TCRC-1 73% 11% stable + 175%
mitochondria
membranes 7





^Heat In. represents heat inactivation. Heat inactivation for human tissues is at
65 C for 10 minutes; for murine lymphoma 55 C for 20 minutes.
^EDTA represents ethylenediamine tetra-acetic acid.
Table 11 (Continued).
Kjjj represents Michaelis constant in mM. Substrate for human tumors is
phenylphosphate. Substrate for murine lymphoma is alpha-naphthyl phosphate.
^AntiP represents Antiplacental isoenzyme. Human tumors were treated with human
placenta antiserum. Murine lymphoma was treated with murine placenta
antiserum. Information comes from Flanigan (1974).
SThis localization assumed from the work of Sasaki and Fishman (1973).
^Fishman et al. (1968) ^
VO
^Fishman et al. (1968)
^Nakayama (1970)
^Higashino et al. (1972)
^Sasaki and Fishman (1973)
^Singer and Fishman (1974)
^Higashino et al. (1975)
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differs from the human Regan isoenzyme in its heat
stability, inhibition by L-phe, H-arg and EDTA, and
histochemical localization. More interesting information
is obtained by comparing the murine lymphoma APase to the
APase of the HeLa cell sublines. The TCRC-1 cell line
APase appears very similar to the Regan isoenzyme while
the TCRC-2 cell line APase is surprisingly similar to the
murine lymphoma APase. Impressive are the similarities of
L-phe and H-arg inhibition, heat lability and histochemical
localization of the two APases. If these two APases from
different systems are similar then one would suspect that
prednisolone would not enhance APase activity of the murine
lymphoma cells. A final test is to perform an ouchterlony
test with the murine lymphoma APase and purified human
placenta APase against anti-TCRC-2 APase antibody to see if
they are immunologically distinct. If the murine placenta
APase is distinct from the human placenta APase but shows
identity with the TCRC-2 APase by this criterion, then the
murine placenta APase may be an appropriate alternate to
study human ovarian cancer as well as human lymphoma.
Noteworthy is the fact that while the placenta is not
similar in all parameters with certain tumors listed
(Table 11), Fishman (1973) calls all the tumors listed
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carcinoplacental enzymes (APase^ in an effort to distinguish
them from carcinofetal (tumors which resemble the fetal
tissue source) enzymes.
Despite the detailed differences between the murine
lymphoma APase and the human placenta and tumor APases, the
analogy between the two systems is evident. In both
systems an enzyme which is normally found in the placenta
is also fotind in the tumor.
The inescapable conclusion is that the APase repre¬
sents the reactivation of a gene which is usually only
active during fetal stages. Mounting evidence in many
systems which indicates that embryonic and fetal proteins,
isoenzymes and antigens appear in malignant cells has been
recently reviewed (Coggin and Anderson, 1973). In the
murine lymphoma system this relationship is made clearer by
the appearance of a similar isoenzyme in the fetal thymus
and in a few cells in the thymic-dependent areas of the
spleen. This provides a system in which a normal dedif¬
ferentiation process, the immune response, can be compared




1. The purpose of this study was to determine if the APase
(NPase) of the lymphoma induced in C57B1 mice is similar to
the APase activities of the normal 16-day fetal thymus,
16-day placenta and adult spleen.
2. To achieve this purpose a biochemical characterization
including pH optimum, heat inactivation, substrate ratio,
Kjjj, activation and inhibition and electrophoretic profiles
was performed.
3. The lymphoma APase appeared similar to the fetal thymus,
placenta and spleen APases by all criteria.
4. Therefore, the lymphoma APase may represent a dere-
|jressed embryonic function. The murine lymphoma APase can
be called a cell membrane carcinofetal enzyme.
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